EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation

Mengxue Zhang, Jing Li, Qingwei Wang, Go Urabe, Runze Tang, Yitao Huang, Jose Verdezoto Mosquera, K Craig Kent, Bowen Wang, Clint L Miller, Lian-Wang Guo

Molecular Therapy - Nucleic Acids · 2023-03 · 31 · 717-729

DOI: 10.1016/j.omtn.2023.02.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy - Nucleic Acids, 2023-03. Verfasst von Mengxue Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetically switched, proliferative vascular smooth muscle cells (SMCs) form neointima, engendering stenotic diseases. Histone-3 lysine-27 trimethylation (H3K27me3) and acetylation (H3K27ac) marks are associated with gene repression and activation, respectively. The polycomb protein embryonic ectoderm development (EED) reads H3K27me3 and also enhances its deposition, hence is a canonical gene repressor. However, herein we found an unexpected role for EED in activating the bona fide pro-proliferative gene Ccnd1 (cyclinD1). EED overexpression in SMCs increased Ccnd1 mRNA, seemingly contradicting its gene-repressing function. However, consistently, EED co-immunoprecipitated with gene-activating H3K27ac reader BRD4, and they co-occupied at both mitogen-activated Ccnd1 and mitogen-repressed P57 (bona fide anti-proliferative gene), as indicated by chromatin immunoprecipitation qPCR. These results were abolished by an inhibitor of either the EED/H3K27me3 or BRD4/H3K27ac reader function. In accordance, elevating BRD4 increased H3K27me3. In vivo, while EED was upregulated in rat and human neointimal lesions, selective EED inhibition abated angioplasty-induced neointima and reduced cyclinD1 in rat carotid arteries. Thus, results uncover a previously unknown role for EED in Ccnd1 activation, likely via its cooperativity with BRD4 that enhances each other's reader function; i.e., activating pro-proliferative Ccnd1 while repressing anti-proliferative P57. As such, this study confers mechanistic implications for the epigenetic intervention of neointimal pathology.

Schlagwörter

Stichwörter der Autor:innen

BRD4 in p57 repressionEED in Ccnd1 activationMT: Oligonucleotides: Therapies and Applicationscooperativity between EED and BRD4epigenetic readersneointimasmooth muscle cell proliferation

Autor:innen und Institutionen

  • Department of Surgery, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
  • Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA 22908, USA.
  • Center for Public Health Genomics, University of Virginia, Charlottesville, VA 22908, USA.
  • Department of Public Health Sciences, University of Virginia, Charlottesville, VA 22908, USA.
  • Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA 22908, USA.
  • Department of Molecular Physiology and Biological Physics, School of Medicine, University of Virginia, Charlottesville, VA 22908, USA.

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • National Heart Lung and Blood Institute
  • American Heart Association

Zitieren

APA

Zhang, M., Li, J., Wang, Q., Urabe, G., Tang, R., Huang, Y., Mosquera, J. V., Kent, K. C., Wang, B., Miller, C. L., & Guo, L. W. (2023). Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation. Molecular Therapy - Nucleic Acids, 31, 717-729. https://doi.org/10.1016/j.omtn.2023.02.024

Vancouver

Zhang M, Li J, Wang Q, Urabe G, Tang R, Huang Y, et al. Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation. Molecular Therapy - Nucleic Acids. 2023;31:717-729. doi:10.1016/j.omtn.2023.02.024

BibTeX
@article{Zhang2023,
  author = {Zhang, Mengxue and Li, Jing and Wang, Qingwei and Urabe, Go and Tang, Runze and Huang, Yitao and Mosquera, Jose Verdezoto and Kent, K Craig and Wang, Bowen and Miller, Clint L and Guo, Lian-Wang},
  title = {Gene-repressing epigenetic reader EED unexpectedly enhances cyclinD1 gene activation},
  journal = {Molecular Therapy - Nucleic Acids},
  year = {2023},
  volume = {31},
  pages = {717--729},
  doi = {10.1016/j.omtn.2023.02.024}
}
Kostenlos starten →